Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study.

HELIUS study Trophic networks atherosclerosis cardiovascular diseases mendelian randomisation microbiome

Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 24 07 2023
revised: 25 10 2023
accepted: 30 11 2023
medline: 30 1 2024
pubmed: 30 1 2024
entrez: 30 1 2024
Statut: aheadofprint

Résumé

Gut microbiota have been linked to blood lipid levels and cardiovascular diseases (CVD). The composition and abundance of gut microbiota trophic networks differ between ethnicities. We aim to evaluate the relationship between gut microbiotal trophic networks and CVD phenotypes. We included cross-sectional data from 3860 individuals without CVD history from six ethnicities living in the Amsterdam region participating in the prospective Healthy Life in Urban Setting (HELIUS) study. Genetic variants were genotyped, fecal gut microbiota were profiled and blood and anthropometric parameters were measured. A machine learning approach was used to assess the relationship between CVD risk (Framingham Score) and gut microbiota stratified by ethnicity. Potential causal relationships between gut microbiota composition and CVD were inferred by performing two sample Mendelian randomization with hard CVD events from the Pan-UK biobank and microbiome GWAS summary data from a subset of the HELIUS cohort (n = 4117). Microbial taxa identified to be associated with CVD by machine learning and Mendelian randomization were often ethnic specific, but some concordance across ethnicities was found. The microbes Akkermansia muciniphila and Ruminococcaceae UCG-002 were protective against ischemic heart disease in African Surinamese and Moroccans, respectively. We identified a strong inverse association between blood lipids, CVD risk and the combined abundance of the correlated microbes Christensenellaceae-Methanobrevibacter-Ruminococcaceae (CMR). The CMR cluster was also identified in two independent cohorts and the association with triglycerides was replicated. Certain gut microbes can have a potentially causal relationship with CVD events, with possible ethnic specific effects. We identified a trophic network centered around Christensenellaceae, Methanobrevibacter and various Ruminococcaceae, frequently lacking in South-Asian Surinamese, to be protective against CVD risk and associated with low triglyceride levels.

Identifiants

pubmed: 38289866
pii: 7593022
doi: 10.1093/cvr/cvae018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

M V Warmbrunn (MV)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

U Boulund (U)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam UMC, Univ of Amsterdam, Cardiovascular sciences, Amsterdam Cardiovascular sciences, Meibergdreef 9, Amsterdam, Netherlands.

J Aron-Wisnewsky (J)

Nutrition and Obesities: Systemic Approaches Research Unit (Nutriomics), Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France; Nutrition Department, Assistantea Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Centres de Recherche en Nutrition Humaine Ile de France.

M C de Goffau (MC)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
HorAIzon BV, 2625 GZ Delft, The Netherlands.
Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Meibergdreef 69, 1105, BK, Amsterdam, The Netherlands.

R E Abeka (RE)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

M Davids (M)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

L R F Bresser (LRF)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
HorAIzon BV, 2625 GZ Delft, The Netherlands.

E Levin (E)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
HorAIzon BV, 2625 GZ Delft, The Netherlands.

K Clement (K)

Nutrition and Obesities: Systemic Approaches Research Unit (Nutriomics), Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France; Nutrition Department, Assistantea Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Centres de Recherche en Nutrition Humaine Ile de France.

H Galenkamp (H)

Department of Public Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

B Ferwerda (B)

Department of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Centers, Amsterdam, Netherlands.

B J H van den Born (BJH)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

A Kurilshikov (A)

University of Groningen, University Medical Center Groningen, Department of Pediatrics, Groningen, Netherlands.

J Fu (J)

University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, Netherlands.

A H Zwinderman (AH)

Department of Public Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

M R Soeters (MR)

Department of Endocrinology & Metabolism, Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

D H van Raalte (DH)

Department of Internal Medicine, Amsterdam University Medical Center (UMC), Vrije Universiteit (VU) University Medical Center, Amsterdam, Netherlands.

H Herrema (H)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

A K Groen (AK)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

M Nieuwdorp (M)

Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Amsterdam UMC, Univ of Amsterdam, Cardiovascular sciences, Amsterdam Cardiovascular sciences, Meibergdreef 9, Amsterdam, Netherlands.

Classifications MeSH